Insider Transactions in Q2 2023 at Clover Health Investments, Corp. (CLOV)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
86,763
-3.06%
|
$0
$0.94 P/Share
|
|
Jun 14
2023
|
Joseph Richards Martin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
98,827
-3.51%
|
$0
$0.94 P/Share
|
|
Jun 14
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
7,776
-0.56%
|
$0
$0.94 P/Share
|
|
May 15
2023
|
Demetrios L. Kouzoukas Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,585
+12.36%
|
-
|
|
May 09
2023
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
28,148
-7.59%
|
$0
$0.93 P/Share
|